Risperdal Lawsuits Increase to Over 20,000 and Climbing
Risperdal Lawsuits Background. On July 11, 2017, the Philadelphia Court of Common Pleas held a status update and discussion on the Risperdal lawsuit file. The purpose was to examine a $70 million verdict that was delivered by a Pennsylvania state court jury in favor of the plaintiff in a Risperdal gynecomastia lawsuit. … [Read more...] about Risperdal Lawsuits Increase to Over 20,000 and Climbing
Risperdal Linked to Enlarged Breasts in Young Men
Risperdal Has Been Linked To Gynecomastia. Parker Waichman LLP is investigating potential lawsuits on behalf of young men who developed gynecomastia (enlarged breasts in men) after taking the antipsychotic medication Risperdal. A number of studies have linked the use of Risperdal to enlarged breast tissue in young men and … [Read more...] about Risperdal Linked to Enlarged Breasts in Young Men
Risperdal Anti-Psychotic Medication Side Effects
Risperdal Serious Side Effects. Parker Waichman LLP is investigating potential lawsuits on behalf of individuals who suffered side effects after taking the anti-psychotic medication Risperdal. This drug, which is manufactured by Johnson & Johnson’s Janssen unit, is used to treat schizophrenia, bipolar disorder, … [Read more...] about Risperdal Anti-Psychotic Medication Side Effects
Makers of Risperdal Manipulated Data on Gynecomastia
Makers of Risperdal is Responsible for Gynecomastia. After a $70 million verdict in a Risperdal gynecomastia lawsuit in July, Janssen Pharmaceuticals and its parent company Johnson & Johnson may be re-examining their strategy for pending Risperdal lawsuits. The lawsuits allege that the Risperdal is responsible for … [Read more...] about Makers of Risperdal Manipulated Data on Gynecomastia
Judge Pauses Philadelphia Risperdal Trial in Data Analysis Dispute
Judge Kenneth Powell of the Philadelphia Court of Common Pleas has paused a trial over an adolescent boy’s breast growth allegedly caused by the antipsychotic drug Risperdal (risperidone) so that the drug maker can turn over more evidence for the boy’s attorneys to review. Janssen Pharmaceuticals Inc., a unit of Johnson & … [Read more...] about Judge Pauses Philadelphia Risperdal Trial in Data Analysis Dispute
